Legionellosis: Difference between revisions
No edit summary |
|||
Line 41: | Line 41: | ||
==Treatment== | ==Treatment== | ||
[[Legionellosis medical therapy|Medical Therapy]] | [[Legionellosis primary prevention|Primary Prevention]] | [[Legionellosis secondary prevention|Secondary Prevention]] | [[Legionellosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Legionellosis future or investigational therapies]] | [[Legionellosis medical therapy|Medical Therapy]] | [[Legionellosis primary prevention|Primary Prevention]] | [[Legionellosis secondary prevention|Secondary Prevention]] | [[Legionellosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Legionellosis future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== |
Revision as of 16:57, 27 November 2012
Legionellosis | |
Legionella pneumophila | |
ICD-10 | A48.1, A48.2 |
ICD-9 | 482.84 |
DiseasesDB | 7366 |
MeSH | D007876 |
Legionellosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Legionellosis On the Web |
American Roentgen Ray Society Images of Legionellosis |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Legionella pneumophila; Legionnaire disease; Pontiac Fever
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Legionellosis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Related Chapters
ca:Legionel·losi da:Legionærsyge de:Legionärskrankheit eo:Legiana malsano he:מחלת הלגיונרים mk:Легионерска болест nl:Veteranenziekte no:Legionærsyken nn:Legionærsjuke fi:Legioonalaistauti sv:Legionärssjuka